Summary. The 37-amino acid islet amyloid polypeptide represents the major protein component present in islet amyloid deposits. Although the presence of islet amyloid is a characteristic pathological feature of the islets of humans, monkeys and cats with Type 2 (non-insulin-dependent) diabetes mellitus, it is not found in the islets of diabetic rats, mice or dogs. To further explore the molecular basis for these species differences in amyloid deposition we have used a polymerase chain reaction based method to clone cDNAs encoding the monkey (Macaca nernestrina) and dog (Canisfamiliaris) islet amyloid polypeptide precursors. The predicted amino acid sequence of the monkey precursor is 96% identical to that of the human protein; differences include one replacement in the signal peptide and three in the islet amyloid polypeptide domain. The sequence of the dog precursor is most closely related to that of the cat protein (85% identity); the sequences of dog and cat islet amyloid polypeptide differ only at two positions and are identical in the region of amino acids 20-29, the region thought to be primarily responsible for amyloidogenesis. Thus, amino acid residues in addition to those at positions 20-29 may facilitate the aggregation of islet amyloid polypeptide. The presence of amyloid deposits in some dog pancreatic endocrine tumours suggests that the dog protein can be amyloidogenic, perhaps due to elevated expression of islet amyloid polypeptide by the tumours relative to normal islets. Islet amyloid polypeptide (IAPP) is a normal secretory product of the pancreatic Beta cell and is a major constituent of amyloid deposits in patients with Type 2 (non-insulin-dependent) diabetes mellitus [1] [2] [3] [4] . The levels of IAPP in the islet and in the peripheral circulation are about 1% those of insulin [5] . The presence of amyloid deposits is the most common pathological lesion seen in the islets of human subjects with Type 2 diabetes. These deposits are also present in the islets of aged individuals although the degree of amyloidosis is much less than that seen in diabetic subjects. Although IAPP is predicted to have hormone-like properties, its normal physiological function(s) are unknown. However, its pathological deposition in the islets disrupts the normal architecture of the islet and may account at least in part for the impaired Beta-cell function seen in patients with Type 2 diabetes. Amyloid deposits have also been noted in the islets of diabetic monkeys [6, 7] and cats [8] ; the protein component of cat islet amyloid has been isolated and partially sequenced and shown to be IAPP [3] . Amyloid deposits also occur in the islets of the diabetic degu, a South American rodent related to the guinea pig; however, the protein component of degu islet amyloid is insulin rather than IAPP [9] .
properties.
Islet amyloid polypeptide (IAPP) is a normal secretory product of the pancreatic Beta cell and is a major constituent of amyloid deposits in patients with Type 2 (non-insulin-dependent) diabetes mellitus [1] [2] [3] [4] . The levels of IAPP in the islet and in the peripheral circulation are about 1% those of insulin [5] . The presence of amyloid deposits is the most common pathological lesion seen in the islets of human subjects with Type 2 diabetes. These deposits are also present in the islets of aged individuals although the degree of amyloidosis is much less than that seen in diabetic subjects. Although IAPP is predicted to have hormone-like properties, its normal physiological function(s) are unknown. However, its pathological deposition in the islets disrupts the normal architecture of the islet and may account at least in part for the impaired Beta-cell function seen in patients with Type 2 diabetes. Amyloid deposits have also been noted in the islets of diabetic monkeys [6, 7] and cats [8] ; the protein component of cat islet amyloid has been isolated and partially sequenced and shown to be IAPP [3] . Amyloid deposits also occur in the islets of the diabetic degu, a South American rodent related to the guinea pig; however, the protein component of degu islet amyloid is insulin rather than IAPP [9] .
Although IAPP-derived amyloid deposits are a feature of diabetes mellitus in humans, monkeys and cats, amyloidosis is not present in the islets of diabetic mice, rats or dogs. The molecular basis for this difference in islet pathology may be related to the structure of the IAPP molecule, especially amino acid sequence differences in the putative fibril-forming region (residues 20-29) [10] . As part of our ongoing studies of the biosynthesis and functional properties of lAPP as well as its role in the impairment of islet function, we have determined the sequences of the IAPP precursors in two useful animal models of diabetes, one of which is characterized by the presence of islet amyloid deposits, the old world monkey, Macaca nemestrina, and the other which is not, the dog, Canisfarniliaris.
Materials and methods
Genomic DNA was prepared from peripheral blood lymphocytes obtained from a single monkey and from two dogs. RNA was isolated from the pancreases of a fasted monkey and dog using the gua- 
Amplification of homologous DNA fragments and rapid amplification of cDNA ends
Amplification of homologous DNA fragments (AHF) was carried out as described previously [11] . Briefly, a 119-base pair DNA fragment coding for mature IAPP was amplified from genomic DNA by the polymerase chain reaction (PCR) using the following two otigonucleotide primers: 5'-AAGTGCAACACTGCCACATGTGC-3' and 5'-CGCTTGCCATATGTATTGGA-T. PCR was carried out for 30 cycles as follows: denaturation for i rain at 94 ~ annealing for 2 min at 50 ~ and extension for 3 min at 72 ~ Amplified fragments of the expected size, 119 base pairs, were isolated, subcloned into the HincII site of M13 mp18, and sequenced by the dideoxy nucleotide chain-termination procedure. The remainder of the sequence of the IAPP precursor nucleotide sequence was obtained using the 5'-and Y-RACE protocol as described previously [11] . The rapid amplification of cDNA ends (RACE) reaction products were subcloned into the HincII site of pGEM4Z, identified by colony hybridization and sequenced. Sequences of six individual clones were usually determined to rule out any errors due to the amplification procedure.
RNA blotting
RNA was separated in a 1.5% agarose-0.66 tool/1 formaldehyde gel, blotted onto nitrocellulose filters, and hybridized with nick-translated cDNA. Filters were washed under high stringency conditions (15 mmol/1 sodium chloride/1.5 retool/1 sodium citrate/0.1% sodium dodecyl sulphate, 60~ and autoradiographed with intensifying screens.
Results
The sequences of monkey and dog IAPP precursors were deduced from nucleotide sequences generated by a combination of AHF and RACE. The cDNA and predicted amino acid sequences of monkey and dog IAPP are shown in Figure 1 . The sizes of monkey and dog pancreatic IAPP mRNA are 2.2 and 2.1 kilobases, respectively, (Fig. 2) indicating that the nucleotide sequences presented in Figure 1 do not correspond to all of the mRNA. The amino acid sequences of IAPP precursors of nine mammals are shown in Figure 3 . The percent identity and similarity between these sequences are summarized in Table 1 . The identity varies from 59-96%. The sequence of the IAPP portion of the precursor is more highly conserved than the other domains which is consistent with IAPP being the only biologically active peptide derived from this protein.
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Discussion
Islet amyloid deposits in association with diabetes have been reported in several species of monkeys, including Macaca nemestrina [6, 7] . In longitudinal studies of Macaca nigra, it was noted that islet amyloidosis preceded development of overt diabetes and the extent of amyloid deposition correlated well with the degree of metabolic deterioration [12] . Furthermore, in view of the relatively close relationship of monkeys to humans, the macaque provides a highly suitable animal model for human Type 2 diabetes. The sequence of the monkey IAPP precursor is very similar to that of the human (96% identity and similarity). Remarkably, no differences were found in the NH2-and COOH-terminal propeptide regions between the monkey and human precursors. In the critical fibrilforming region, i. e. residues 20-29, monkey IAPP differs by only one amino acid from that of human: residue 25, which is alanine in human and cat lAPP, is changed to threonine. Since the substitution of proline for alanine at position 25 in human IAPP had only minor effects on its in vitro fibril-forming ability [10] , the threonine substitution at this position in monkey IAPP is unlikely to cause a significant reduction in its amyloidogenic properties.
Although dogs have IAPP immunoreactivity in the Beta cells of their pancreases, diabetic animals do not develop islet amyloidosis. Moreover, a recent report of the partial sequence of dog IAPP indicated that it is very simi- Human  92  92  92  86  86  89  78  78  Monkey  92  89  89  86  86  84  76  76  Cat  89  86  100  95  95  92  84  86  Dog  89  86  95  95  95  92  86  86  Rat  84  84  89  89  100  92  84  86  Mouse  84  84  89  89  100  92  84  86  Hamster  86  81  86  86  92  92  78  78  Guinea pig  78  76  81  84  84  84  78  95  Degu  78  76  84  84  86  86  78  95  B. IAPP precursor  Percent identity  Human  96  85  89  73  73  74  72  71  Monkey  96  85  89  74  74  72  72  71  Cat  81  81  92  77  76  71  72  73  Dog  82  82  85  80  80 lar to that of the cat, a species known to have such deposits [13] . Our results confirm that the sequences of dog IAPP and its precursor are closely similar to those of the cat (95% and 85% identity, respectively [ Fig.3 , Table 1] ). In the fibril-forming region of IAPR the amino acid sequence of dog IAPP is identical to that of the cat, as recently reported [13] . However, our sequence differs from that reported by Jordan et al. [13] ; there are three nucleotide differences, one of which results in an amino acid difference. Residue 34 of dog IAPR which is serine in our sequence and in eight other mammals, is threonine in the report by Jordan et al., perhaps indicating an allelic difference in this species. However, both of the dog samples studied in this work gave identical prepro IAPP sequences. From the results of our present study, the sequence of dog IAPP differs by only two amino acids from that of the cat, at residues 18 and 20. It is possible that one or both of these changes may account for the absence of islet amyloid deposits in diabetic dogs. The mRNA levels in Northern analysis appear to be comparable in dog and monkey pancreases (Fig.2) , but there could be differences in the translational efficiency of these mRNAs in these two species. A recent study demonstrated the presence of IAPP-immunoreactivity in amyloid deposits associated with pancreatic endocrine tumours in dogs [14] . This finding suggests that increased expression of IAPP or its precursor, as may occur in such tumours (18; ref. 19 , unpublished results) plays a role in the generation of these amyloid deposits. The reasons for the absence of such deposits in the islets of diabetic dogs remain unclear but, if not the result of reduced levels of expression of IAPP in dogs relative to other species, may indicate that the threshold concentration of IAPP required to initiate the aggregation of dog IAPP into fibrils is higher than that for the cat or human proteins and these levels are not normally exceeded in diabetic dogs whereas they may be in pancreatic endocrine tumours.
